Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
European Heart Journal|September 26, 2015
Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction-TROFI II trialManel Sabaté, Stephan Windecker, Andres Iñiguez, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 13, 2016
Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel diseaseJavier Escaned, Adrian Banning, Vasim Farooq, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 19, 2016
Design and rationale for a randomised comparison of everolimus-eluting stents and coronary artery bypass graft surgery in selected patients with left main coronary artery disease: the EXCEL trialArie Pieter Kappetein, Patrick W Serruys, Joseph F Sabik, et al.
JACC. Cardiovascular Interventions|September 26, 2009
Impact of vessel size on angiographic and clinical outcomes of revascularization with biolimus-eluting stent with biodegradable polymer and sirolimus-eluting stent with durable polymer the LEADERS trial substudyJoanna J Wykrzykowska, Patrick W Serruys, Yoshinobu Onuma, et al.
American Heart Journal|December 5, 2016
Rationale and design of the Transcatheter Aortic Valve Replacement to UNload the Left ventricle in patients with ADvanced heart failure (TAVR UNLOAD) trialErnest Spitzer, Nicolas M Van Mieghem, Philippe Pibarot, et al.
Circulation|June 13, 2018
Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus DocumentHector M Garcia-Garcia, Eugène P McFadden, Andrew Farb, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 22, 2010
The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymerScot Garg, Giovanna Sarno, Patrick W Serruys, et al.
European Heart Journal|June 14, 2018
Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus DocumentHector M Garcia-Garcia, Eugène P McFadden, Andrew Farb, et al.
Lancet (London, England)|November 15, 2011
Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trialGiulio G Stefanini, Bindu Kalesan, Patrick W Serruys, et al.
Lancet (London, England)|September 4, 2008
Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trialStephan Windecker, Patrick W Serruys, Simon Wandel, et al.
Pageof 9